SNYDER: Watching (and cheering) as Murray calls his shot
Every now and then, the tables are reversed, the script is flipped, and an athlete has leverage on the system.
Opinion
Featured Articles
Trump is about to get the attorney general he wished for. Now what?
- The Washington TimesRelated Articles
In the current world climate, nice Canadians finish last
On a recent trip to Montreal, I was disturbed by a billboard that greeted me just outside the city's main train station: an ad for Huawei, the "controversial" Chinese technology company.
Suiting up for a trade war
The United States and China are drifting into a trade war, and it's worrying almost everybody. It's a peculiar war, compared to such struggles of previous centuries. Its importance is sometimes minimized in importance because of the blind spots both countries have for one another. Neither country seems to have an adequate appreciation of the other's very different environment.
Fraught lives and an animate piano
The piano in Chris Cander's novel is made from spruce, selected from a snowy Romanian forest by Joseph Bluthner, who only ever chose the very best trees: Old ones with at least seven annular rings per centimeter. From these he made the pianos that bear his name. Famed for their warmth of tone they "were beloved of the likes of Schumann and Liszt."
Rap the elephant in the room
The Gillette company is getting well-deserved blowback this week over their "toxic masculinity" shaving cream ad, which has many viewers signaling for a time out. Masculinity is not toxic, but in fact life-protecting and life-nurturing, just as much as femininity is.
Sweep out bogus patents
A recent op-ed spoke to the need for bipartisan solutions to lower drug prices ("Double jeopardy on patents discourages drug innovation," Web, Jan. 2). But under the banner of "protecting drug innovation," it conflates two distinct processes: the role of drug patents under the Hatch-Waxman Act and a newer process created by Congress to clear the system of flimsy, improperly issued patents (known as IPR, or inter partes reviews). This patent obfuscation and defense of every single drug patent — even weak ones — at all costs is one big reason American consumers pay the highest drug prices on the planet.
CNN's Don Lemon: Trump is a bigot, America's racist and I belong on $100 bill
CNN's Don Lemon, in a discussion with fellow CNNer Chris Cuomo about Rep. Steve King's "white supremacist" remark to The New York Times, called out President Donald Trump as a bigot, going so far to say that calling him that was not opinion, but fact. And then he suggested all of Trump supporters were the same.
Religious Freedom Day, a time to reflect -- and fight
Religious Freedom Day is being celebrated at choice spots around the nation, giving Americans who take such matters for granted a brief moment in time to consider: Not all have it so First Amendment-y free and easy. In fact, a look at the statistics show most don't have it so free and easy when it comes to worshipping.
LOVERRO: Hall of Famers should be selected for impact, not just stats
Voting has already taken place among the eligible baseball writers, and the results will be revealed on Tuesday, Jan. 22. Many ballots have already been made public by voters, and I'll make mine public here. But as I have often said, the vote often turns into a venom-filled referendum on truth and justice instead of simply a decision about a baseball player's career.
© Copyright 2019 The Washington Times, LLC
3600 New York Avenue NE, Washington, DC 20002
